Cyfuse Biomedical K.K. (TYO:4892)
Japan
· Delayed Price · Currency is JPY 924.00
+8.00 (0.87%)
May 23, 2025, 3:30 PM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 7.67 billion as of May 23, 2025. Its market cap has increased by 39.08% in one year.
Market Cap
7.67B
Enterprise Value
5.67B
Revenue
68.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
924.00
Market Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 7.67B, a decrease of -40.98%. That is a compound annual growth rate of -19.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 7.67B | 108.70% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.37T |
| Daiichi Sankyo Company | 7,005.55B |
| Takeda Pharmaceutical Company | 6,478.50B |
| HOYA Corporation | 6,013.45B |
| Terumo | 3,972.78B |
| Otsuka Holdings | 3,503.09B |
| Astellas Pharma | 2,489.14B |
| Olympus | 2,062.20B |